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Abstract—The recent advancements in electrochemical measurements are guiding the development of new platforms for
in-situ point-of-care monitoring of human-metabolite, markers and drugs. Despite this, the application of Voltammetry-
Based Sensing (VBS) techniques is still limited in wearable, portable, or IoT systems. In order to use VBS approaches
to measure analytes in small and low-power electronic platforms for diagnostics, several improvements are required. For
example, the definition of a method to achieve the right trade-off between sample rate and sensing performance is still
missing. To develop a method to define the best sampling rate, we present here an extensive analysis of experimental data
to prove that is feasible to detect drugs such as paracetamol by Staircase Cyclic Voltammetry (SCV) or Differential Pulse
Voltammetry (DVP) direct detection methods, with low sampling frequency. Our results prove that the proposed method
helps the development of systems capable of discriminating the minimum pharmacology concentration of the metabolite
under analysis with a massive reduction of the sampling frequency.
Index Terms—Bio-sensor, Cyclic Voltammetry, Differential Pulse Voltammetry, Electrochemical Sensors, Low Power, IoT, Paracetamol,
Point-of-care, Sampling Rate, Wearable.
I. INTRODUCTION
The real-time point-of-need biochemical sensing provides the
possibility of direct non-invasive monitoring of patients, giving
continuously valuable insights into their health and their well-being.
Electro-analytical measurements can be directly exploited in-situ and
without sample purification. This brings the benefit of a point-of-care
detection of several different analytes and drugs on wearable, portable,
and IoT systems [1]. If we consider this new scenario, the portable
devices strongly constraint the maximum power consumption of the
system. In order to enlarge the battery life-time, one possible approach
is the reduction of the sampling rate of the sensing node [2], leading
to a reduction of data density and signal bandwidth. In fact, the key
components of the power consumption in the device are related to
the power spent by signal elaboration and data transmission, which
are both directly influenced by the sampling rate.
Potentiometric and amperometric techniques, for example, Open-
Circuit Potential (OCP) [3] and Chrono-Amperometry (CA) [4], are
usually exploited in wearable devices for electrochemical sensing
thanks to their capability of carrying out the bio-sensing information
through a low-complexity electrical-converter. In those cases, the
sampled information (concentration of analyte), is directly related
to an electrical quantity, voltage or current. The ratio between the
number of samples and the number of information detected is one,
implying an information throughput equal to one. Nevertheless, OCP
and CA are not suitable for the detection of all the possible analytes,
due to the higher variability and the poor stability over time of micro
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reference electrodes [5].
The voltammetry-based electro-analytical tools are largely used
in electrochemistry to obtain quantitative information on RedOx
processes in a laboratory environment [6]. Thanks to the recent
advancement in electronics, the Voltammetry Based Sensing (VBS)
techniques are appearing on the scene as methods for direct sensing
at the point-of-need [7]–[9]. In VBS, the electrochemical cell is
excited by a voltage sweep applied between its Working Electrode
(WE) and its Reference Electrode (RE). The current produced by
the oxidation or the reduction of the target species is then measured
from the Counter Electrode (CE) or equivalently from the WE. This
current usually is reported versus the applied potential obtaining the
so-called voltammogram. The voltammogram has a peculiar shape
that depends, for example, on the drug present in the solution with
current peaks corresponding to RedOx phenomena. From the height
of these peaks, it is so possible to evaluate the concentration of
the drug [10]. The indirect method of measuring through peak-
determination in VBS introduces complexity and increases the data
bandwidth (w.r.t. OCP and CA). The throughput is no more one: to
sense one sample of concentration, we have to sample more than
one time the current. However, the higher complexity of the method
increases specificity and sensitivity [10] and provides simultaneous
determination of different compounds [11]. To be effective, the VBS
approach requires the sampling of a well-defined voltammogram.
Despite the massive literature, at the best of our knowledge, a real
definition of the optimal sampling rate does not exist. This value
is usually set by empirical methods, for example, considering how
many data points are forming the complete voltammogram graph.
Therefore, as already suggested by [12]–[14], there is the need for a
novel and effective method for reducing and optimizing the sampling
rate in VBS.
The preliminary results here presented are necessary to quan-
titatively prove that the data produced by VBS techniques can
be efficiently down-sampled. The final results demonstrate the
efficient application of a sampling rate optimization method on
a full set of in-vitro measurements, considering as test case the
sensing of acetaminophen, also known as paracetamol and N-acetyl-
p-aminophenol (APAP), a widely used analgesic [15].
A. Staircase Cyclic Voltammetry and Differential Pulse
Voltammetry
[12]–[14] consider the Fast Scan Cyclic Voltammetry (FSCV)
for neurotransmitters, a specific case where the sample rate is
limited by communication bandwidth. Differently, to the best of
our knowledge, for the first time, we here investigate more general
methods like Staircase Cyclic Voltammetry (SCV) and Differential
Pulse Voltammetry (DPV) for drug monitoring.
The APAP can be sensed either through SCV or DPV with simple
devices for continuous monitoring 1 describes those methods. The
SCV (Fig. 1a) procedure requires the application of a driving voltage
ramp between WE and RE, that generally is generated through a
staircase of voltage step, defined by a voltage height (Vstep) and a
time length (tstep). The voltage scan ranges in an interval related to
the RedOx process under analysis. The ratio between Vstep and tstep
is also called Scan Rate (SR). Every sampling time interval tsample,
a current sample is acquired from the CE/WE loop. According to
the Randles-Sevcik equation [10], is possible to derive the analyte
concentration by processing the voltammogram to detect the height
of the current peak [6]. The DPV (Fig. 1b) adds to the staircase a
pulse wave signal and introduces as main advantages the reduction of
non-Faradic current related to double layer effect, the enhancement
of the current peak, and the reduction of noise [16]. Typically, SCV
is applied to detect both oxidation and reduction peaks, while DPV
only for one kind of reaction, for this reason, the voltage-scan ranges
can be different in the two methods.
Fig. 1. SCV (a) and DPV (b) methods examples, the cell is driven by
the wave (right) to acquire the voltammogram (left). The output can be
elaborated in the calibration curve (c).
From electrochemical determination, is possible to derive a
calibration curve (Fig. 1c) which is the relation between the
concentration of analyte and the current (in VBS the height of
the current-peak). Typically, the calibration curves form of a straight
line in the region of interest, and the Sensitivity (S) represents the
slope of this curve. The parameter Limit of Detection (LOD) specifies
the minimum quantity of an analyte that can be determined.
II. METHODS
A. Materials and Equipment
APAP powder from Sigma Aldrich® (Acetaminophen BioXtra,
≥ 99 %) in the day of use is dissolved in a background electrolyte,
namely, Phosphate Buffer Saline (PBS) solution at pH 7.4. The
buffer is purchased from Sigma Aldrich® and it is composed of
10 mM phosphate buffer, 2.7 mM potassium chloride, and 137 mM
sodium chloride. The sensing equipment is composed of a commercial
potentiostat, namely the Metrohm Autolab PGSTAT 302N, driven by
the software Nova 1.11. The instrument is interfaced using DropSens
DRP-110, Screen-Printed Electrode (SPE) composed of carbon WE
with 4 mm diameter, carbon CE, and silver (pseudo-) RE [17] for
the drug-detection.
B. In Vitro Data Collection
For the preliminary analysis, a sample containing 300 µM of
APAP is selected as a reference measure, since this value is the
maximum in the therapeutic range [15]. A parametric analysis is
performed in SCV considering a different number of samples per
voltammogram, equivalently, varying the sampling frequency (FS).
The SR is set to 0.2 V/s, the driving voltage ranges in – 0.1 : 1.1 V,
while the step voltage height ranges in 1 : 24 mV, and the step
time length ranges in 5 : 120 ms. For the final analysis, a full seven-
points calibration procedure in the therapeutic range 50 : 300 µM is
performed. Subsequent increasing concentration steps of 50 µM of
APAP are measured. To consider the inter-electrode variability and
to avoid artifacts, the measurement is repeated three times for each
condition with a new electrode. The SCV is performed with a SR of
0.2 V/s, with a driving voltage ranging in – 0.1 : 1.1 V, with a step
voltage height of 6 mV, and a step time length of 30 ms. The DPV
is performed at 0.1 V/s, in the range 0 : 1 V, with a step height of
6 mV, an step length of 60 ms, the pulse amplitude is set to 60 mV,
and the pulse time length to 30 ms.
C. Peak Detection and Elaboration
The collected data are processed in Matlab® (v. R2017b). After
subtracting the background-current obtained by the blank measure-
ment, the peaks are detected and analysed with the findpeaks
built-in function to return the height of the oxidation-current peak and
its position. The calibration curve, the sensitivity and the coefficient
of determination (r2) are derived by regression built-in function.
The LOD is computed as three times the standard deviation of the
blank measure around the peak, divided by S.
III. RESULTS AND DISCUSSION
A. Preliminary Analysis
Considering the main parameters of SCV and DPV methods as
the Scan Rate (SR), the total number of samples acquired per ramp
(NS), and the full voltage scan interval (Vscan), is possible to define
the sampling frequency (FS) as in (1). The equation gives us three
degrees of freedom to reduce the sampling rate, but, considering a
fixed analyte and a fixed electrochemical sensor, only the reduction
of the number of samples seems easy practicable. The voltage scan
interval is determined by the reaction under analysis and also the
SR is a variable which should be primarily optimized considering
the diffusivity of the reaction under analysis [18].
FS = SR · NSVscan (1)
As a preliminary analysis, a set of lab measurements is considered
varying the number of steps per SCV, fixing all the other parameters.
Fig. 2 presents graphically the results. In Fig. 2a the y-axis shows
the peak-current error. The error is defined as the difference between
the best possible estimation of the peak we can dispose of (i.e.
sampling the current with the maximum sampling frequency granted
by the instrument [19]) and a given approximation of the estimated
peak (i.e. sampling the current with a given frequency, x-axis). The
error quasi-linearly depends on the sampling period. This effect
is due to the lower resolution in the peak measurement, but it is
also highly influenced by the increase of voltage step height [20].
Fig. 2b analyzes the Signal to Noise Ratio (SNR, y-axis) versus the
sampling frequency. Two different values are taken into account: the
SNR of the full voltammogram, and the SNR of only the detected
output, i.e. the SCV peak value. The SNR is defined considering
the signal (S) as the full voltammogram or the detected peak at the
maximum possible sampling rate, while the noise (N) is the difference
between the signal (S) and the output voltammogram or peak at the
given sampling frequency. The noise introduced by the reduction
of sampling frequency is visibly lower considering the SCV-peak
with respect to the noise present in the full voltammogram. This
happens because the peak detection is not a linear operator, but a
feature-extractor, acting to some extent as a filter. The output in
which we are interested to develop the electrochemical sensor is
primarily the peak height. This analysis proves that is feasible to
reduce of the sampling rate over what is usually considered the limit
because the noise introduced in the voltammogram does not reflect
linearly to the increase of noise in the output measure.
Fig. 2. Analysis of SCV output varying sampling rate. (a) Peak error
percentage (w.r.t maximum). (b) SNR ratio (w.r.t. maximum) of full
voltammogram (SCV-voltammogram) and detected peaks (SCV-peak).
B. Reduction of Sampling Rate
For the final analysis, two sensing methods are taken into account,
SCV and DPV. The data collected using the seven-points calibration
are analyzed progressively halving the sampling frequency from 33 Hz
down to 0.1 Hz. The selected range of frequency is derived from
the literature and instrument (Autolab) indications [19]. The output
current is re-sampled with an increasingly higher sampling interval
(tsample). Otherwise, the input driving voltage ramp is unvaried, to
avoid any effect related to the increase of the voltage step (Vstep). The
down-sampling procedure visibly reduces the quantity of information
in the voltammogram. Fig. 3 presents some points of the analysis
for demonstration purpose. Fig. 4 reports graphically the results of
this analysis from 33 Hz down to 0.6 Hz. The results below this
frequency are not valid since it is not possible to retrieve anymore
useful information from the voltammogram. The parameters under
investigation are the sensitivity (4a), the LOD (4b), the current
peak position (4c), and the linearity of the calibration curves (4d).
Fig. 3. Resulting voltammograms in SCV (a) and DPV (b), varying the
sample-rate.
Fig. 4. Effect of down-sampling w.r.t. sampling frequency in SCV and
DPV: (a) sensitivity, (b) LOD, (c) voltage peak position, (d) calibration
curve linearity.
TABLE 1. Comparison between empirical-defined sampling rate ap-
proach and the proposed optimal sampling rate approach.
Empirical approach Proposed approach
SCV DPV SCV DPV
Number of sample 404 338 51 22
Sampling frequency (Hz) 33.3 33.3 4.2 2.2
Sensitivity (nA/µM) 50.5±3.6 59.0±5.7 47.5±3.5 57.8± 7.3
LOD (µM) 1.50±0.11 0.45±0.04 2.27±0.16 1.15± 0.60
Peak position (mV) 406±11 379±18 405±80 383± 40
Linearity * 0.999 0.995 0.999 0.988
* Coefficient of determination, r2
The measurement errors are evaluated from the experimental data
considering three times the standard deviation on each computed
parameters. In all the graphs the measurement error increases visibly
with the reduction of the sampling rate. The DPV method compensates
the sensing-errors applying a differential detection and consequently
enhances the LOD. The peak position remains stable varying its
resolution, proving the selectivity. The linearity shows a drop in the
DPV method below 2.2 Hz, defining a clear limit in the proposed
experimental set-up.
Considering the data reported in Fig. 4, is possible to find the right
trade-off which minimizes the sampling rate, without affecting the
performance of drug-sensing. Since the minimum therapeutic range
of paracetamol of 50 µM, we define that in the optimal approach the
LOD cannot exceed one order of magnitude this value (i. e. 5 µM is the
minimum LOD requirement). Moreover, we consider the drop in the
linearity of DPV and we force the maximum S uncertainty to be lower
than 10 %. We derive from the literature that usually the experiments
are conducted with an empirical a priori defined sampling rate of
more than some hundred samples per voltammogram [6]–[9], [19].
Table 1 shows a comparison between the empirical approach and the
here presented approach. Thanks to the here presented optimization
methodology, the LOD increases but remains in all cases under the
imposed maximum. Sensitivity scales down to 94 % of the standard
with SCV method, and to 97 % with DPV. Meanwhile, the sampling
frequency can be reduced by eight times in the SCV and sixteen times
in the DPV. If we consider the DPV method and our approach, this
reflects on an astonishing reduction down to 6.6 % of the sampling
frequency, with a LOD still suitable for the application, loosing just
2 % in sensitivity.
IV. CONCLUSION
In the presented work, the results demonstrated how we can balance
the performance to appropriate sampling rate and power consumption
in voltammetry-based electrochemical sensing. Lowering the sam-
pling rate the power consumption of the device diminishes, helping
the realization of optimized electronic platforms able to provide
non-invasive real-time point-of-care bio-sensing, targeting IoT and
wearable applications. In particular, we established that is possible
to develop a method to reduce the sampling frequency maintaining
all the sensing performance in the range of the system requirements.
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